Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis (Q35030822)

5 August 2017

1 reference

title

Review article: immunopathogenetic and therapeutic aspects of autoimmune hepatitis (English)

1 reference

5 August 2017

1 reference

Medina J

1 reference

5 August 2017

García-Buey L

series ordinal

1 reference

5 August 2017

Moreno-Otero R

series ordinal

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Alimentary Pharmacology & Therapeutics

5 August 2017

published in

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

1-16

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

5 August 2017

1 reference

Hepatocellular carcinoma in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Persistent measles virus genome in autoimmune chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Pathogenesis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Intrahepatic enhanced expression of beta2-microglobulin conformational epitope in acute liver allograft rejection: evidence of modulation by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Argininosuccinate lyase: a new autoantigen in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Understanding the pathogenesis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

The molecular genetics of autoimmune liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Diagnosis and therapy of autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Current and novel immunosuppressive therapy for autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Management and outcome of pregnancy in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Short-term cyclosporine induces a remission of autoimmune hepatitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Oral tolerance in the treatment of inflammatory autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Lessons about antibodies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon alfa-2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Serum levels of cytokines in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Early-onset autoimmune hepatitis is associated with a C4A gene deletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Autoimmune hepatitis: the investigational and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Liver transplantation for autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

Recurrence of autoimmune hepatitis in children after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

OUTCOME OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01389.X

10.1046/J.1365-2036.2003.01389.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference